V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160012127 | 160017486 | 1.73 | 65.1 | null | 2021-02-06 | 2021-02-06 | NIVOLUMAB | null | null | NIVOLUMAB | 100571727 |
| 160012128 | 160017487 | 1.65 | null | null | 2022-04-05 | 2022-04-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100878492 |
| 160012133 | 160017488 | 1.62 | 95.4 | Palliative (P) | 2021-09-20 | 2021-09-22 | NIVOLUMAB | 99 | null | NIVOLUMAB | 101269522 |
| 160012141 | 160017489 | 1.68 | 61.9 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | TRABECTEDIN | 100677858 |
| 160012142 | 160017490 | 1.68 | 61.8 | Palliative (P) | 2021-08-28 | 2021-09-03 | Vinorelbine (oral) | 2 | N | VINORELBINE | 100754439 |
| 160012153 | 160017491 | 1.65 | 63 | Palliative (P) | 2020-09-02 | 2020-09-07 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100603299 |
| 160012192 | 160017492 | 1.72 | null | Palliative (P) | 2021-10-11 | 2021-10-12 | VINORELBINE | 02 | null | VINORELBINE | 101171512 |
| 160012194 | 160017493 | 1.82 | 87.7 | Palliative (P) | 2022-04-20 | 2022-05-05 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 100568797 |
| 160012199 | 160017494 | 1.72 | 97 | Palliative (P) | 2018-06-19 | 2018-06-28 | Doxorubicin 75mg/m2 | 02 | N | VINORELBINE | 101314332 |
| 160012225 | 160017496 | 1.73 | 106.8 | null | 2017-07-21 | 2017-08-01 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101417475 |
| 160012232 | 160017497 | 1.5 | 79.1 | Palliative (P) | 2020-01-04 | 2020-05-14 | Doxorubin 50mg/m2 | 02 | N | DOXORUBICIN | 100614076 |
| 160012234 | 160017498 | 1.73 | 61 | Palliative (P) | 2022-05-10 | 2022-05-28 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 100784164 |
| 160012241 | 160017499 | 1.87 | 75.4 | Palliative (P) | 2016-12-01 | 2016-12-14 | Doxorubicin 75mg/m2 | 02 | N | NIVOLUMAB | 100195156 |
| 160012245 | 160017500 | 1.56 | 81 | Palliative (P) | 2019-12-27 | 2020-02-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100014571 |
| 160012251 | 160017501 | 1.77 | 83.2 | null | 2021-10-13 | 2021-10-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100720359 |
| 160012257 | 160017502 | 1.8 | 87 | null | 2020-06-11 | 2020-07-26 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100425878 |
| 160012270 | 160017503 | 1.65 | 108.8 | Palliative (P) | 2017-08-14 | 2017-08-21 | Doxorubicin 75mg/m2 | N | null | DOXORUBICIN | 101046547 |
| 160012273 | 160017504 | 1.72 | 80 | null | null | 2020-04-13 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101600461 |
| 160012277 | 160017505 | 1.52 | 64.3 | null | 2019-07-30 | 2019-07-31 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101816373 |
| 160012278 | 160017506 | 1.77 | 66.6 | null | 2020-11-16 | 2020-11-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101740566 |
| 160012282 | 160017507 | 1.6 | 97 | null | 2020-08-26 | 2021-02-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100069395 |
| 160012298 | 160017508 | 1.75 | 77.8 | null | 2022-03-18 | 2022-03-22 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100124672 |
| 160012301 | 160017509 | 1.75 | 72.6 | Palliative (P) | 2018-04-07 | 2018-04-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101789839 |
| 160012304 | 160017510 | 1.71 | 55.1 | Palliative (P) | 2022-03-20 | 2022-03-24 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100231334 |
| 160012311 | 160017511 | null | 95.05 | Palliative (P) | 2021-04-26 | 2021-04-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100063852 |
| 160012328 | 160017512 | 1.73 | 61 | Palliative (P) | 2021-06-11 | 2021-06-27 | Trabectedin | 02 | N | TRABECTEDIN | 100204964 |
| 160012334 | 160017513 | 1.72 | 70.3 | Palliative (P) | 2018-07-26 | 2018-08-08 | Trabectedin | 02 | N | TRABECTEDIN | 100059008 |
| 160012365 | 160017514 | 1.82 | 70 | Palliative (P) | 2019-12-26 | 2020-01-02 | Trabectedin | 02 | N | TRABECTEDIN | 100655541 |
| 160012371 | 160017515 | 1.79 | 81.4 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | VINORELBINE | 101140575 |
| 160012372 | 160017516 | 1.75 | 76 | null | 2021-06-09 | 2021-06-10 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100676178 |
| 160012392 | 160017517 | 1.65 | 65.2 | Palliative (P) | 2019-12-07 | 2019-12-21 | Vinorelbine (oral) | null | N | VINORELBINE | 101814473 |
| 160012393 | 160017518 | 1.76 | 66.3 | null | 2019-05-11 | 2019-05-11 | DOXORUBICIN | null | null | TRABECTEDIN | 100027831 |
| 160012407 | 160017519 | 1.68 | 116.1 | null | 2019-09-29 | 2019-10-12 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101755774 |
| 160012426 | 160017520 | 1.68 | 63.4 | null | 2021-04-30 | 2021-05-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100152789 |
| 160012427 | 160017521 | 1.73 | 68.8 | null | 2021-07-26 | 2021-07-29 | DOXORUBICIN | 02 | null | NIVOLUMAB | 101683542 |
| 160012433 | 160017522 | null | 72.3 | null | 2021-03-23 | 2021-04-05 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100019810 |
| 160012447 | 160017523 | 1.75 | 65.5 | Palliative (P) | null | null | Trabectedin | 02 | N | TRABECTEDIN | 101611569 |
| 160012451 | 160017524 | null | 81.6 | null | 2017-02-02 | 2017-02-05 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100650732 |
| 160012455 | 160017525 | 1.6 | 76.4 | Palliative (P) | 2018-10-19 | 2018-10-30 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100067373 |
| 160012456 | 160017526 | 1.82 | 75 | Palliative (P) | 2019-08-11 | 2019-12-24 | VINORELBINE | 02 | N | VINORELBINE | 101538361 |
| 160012469 | 160017527 | 1.75 | 73 | null | 2018-09-22 | 2018-09-29 | Trabectedin | 02 | null | TRABECTEDIN | 101828979 |
| 160012471 | 160017528 | 1.68 | 82.7 | Palliative (P) | 2020-03-18 | 2020-03-18 | Doxorubicin 75mg/m2 | 02 | null | TRIAL UNSPECIFIED | 100906104 |
| 160012483 | 160017529 | 1.77 | 90.9 | null | 2020-12-15 | 2020-12-31 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101868303 |
| 160012488 | 160017530 | 1.62 | 77.6 | Palliative (P) | null | 2021-07-30 | Doxorubicin 75mg/m2 | 02 | N | NIVOLUMAB | 101056923 |
| 160012492 | 160017531 | 1.6 | 71.7 | null | null | 2021-06-10 | Doxorubicin 75mg/m2 | 02 | null | NIVOLUMAB | 100954195 |
| 160012498 | 160017532 | 1.64 | 94.2 | null | 2016-07-10 | 2016-11-01 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101189852 |
| 160012501 | 160017533 | 1.59 | 0 | null | 2016-12-07 | 2016-12-07 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100360893 |
| 160012515 | 160017534 | 1.85 | 58 | null | null | 2022-04-19 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101705362 |
| 160012518 | 160017535 | 1.85 | 97 | Palliative (P) | 2018-01-04 | 2018-01-05 | Trabectedin | 02 | N | TRABECTEDIN | 100889455 |
| 160012524 | 160017536 | 1.62 | 73.5 | Palliative (P) | 2021-10-30 | 2022-03-06 | Trabectedin | 02 | N | TRABECTEDIN | 101816465 |